copyright Pen has emerged as a groundbreaking therapy for type 2 diabetes. This innovative injectable medication utilizes the power of a glucagon-like peptide-1 receptor agonist to effectively reduce blood sugar levels. Clinical trials have demonstrated copyright Pen's success rate in enhancing glycemic control, leading to a substantial reduction i